secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2024-10-11T23:59:59+00:00
Accession:  0001493152-24-040953
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics enters $5.1M ATM equity offering with Ladenburg Thalmann
-------------------------------------------------------------------------------

- Company may sell up to $5.1M of common stock through ATM facility with Ladenburg Thalmann.
- Commission of 3.0% on gross proceeds; expenses up to $50k reimbursable.
- Shares sold at market prices; offering pursuant to effective S-3 registration statement.
- Company not obligated to sell any shares; can suspend at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224040953/0001493152-24-040953-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224040953/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-040953

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer